fbpx Skip to content

Migraine and Headache Disease‑Specific Clinical Trials

More research is needed to help find safe and effective treatments for people living with migraine and headache disease. As we are made aware of clinical trials that may be of interest to our community, we will post links on this page.

Accellacare

Biohaven BHV3500-302- adult migraine study (18+), must be diagnosed with migraine >1 year; in last 3 months, must have at least 8 migraines and at least 15 headaches per month  (investigational nasal product).

Satsuma  STS101-007 – adult migraine (18+), experiencing 2-8 migraines per month (investigational nasal spray).

Eli Lilly H8H-MC-LAHV- pediatric migraine study (ages 6-17), must have at least 2-8 moderate-to-severe migraines per month in past 2 months and is as least 33lbs and can swallow a tablet.

A Study in Children with Migraine

Lundbeck

A pediatric migraine study is seeking particpants to help test a study drug for migraine in children.

To qualify for this study, your child must:

  • Be a male or female aged 6 to 11 years of age
  • Have migraine that have been diagnosed by a doctor for at least 6 months
  • Have a migraine at least 4 days per month for at least the past 3 months
Scroll To Top